{
  "actions": [
    {
      "acted_at": "2019-04-01",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2019-04-01",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2019-04-02",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr2011-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "C001120",
      "district": "2",
      "name": "Crenshaw, Dan",
      "original_cosponsor": false,
      "sponsored_at": "2019-06-27",
      "state": "TX",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "G000576",
      "district": "6",
      "name": "Grothman, Glenn",
      "original_cosponsor": false,
      "sponsored_at": "2019-05-22",
      "state": "WI",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "G000558",
      "district": "2",
      "name": "Guthrie, Brett",
      "original_cosponsor": true,
      "sponsored_at": "2019-04-01",
      "state": "KY",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "R000585",
      "district": "23",
      "name": "Reed, Tom",
      "original_cosponsor": true,
      "sponsored_at": "2019-04-01",
      "state": "NY",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S001216",
      "district": "8",
      "name": "Schrier, Kim",
      "original_cosponsor": true,
      "sponsored_at": "2019-04-01",
      "state": "WA",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2019-04-01",
  "number": "2011",
  "official_title": "To amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biologics license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "s1140-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "s1895-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "Protecting Access to Biosimilars Act of 2019",
  "sponsor": {
    "bioguide_id": "D000197",
    "district": "1",
    "name": "DeGette, Diana",
    "state": "CO",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2019-04-01",
  "subjects": [
    "Allergies",
    "Blood and blood diseases",
    "Drug safety, medical device, and laboratory regulation",
    "Health",
    "Health promotion and preventive care",
    "Health technology, devices, supplies",
    "Immunology and vaccination",
    "Licensing and registrations"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2019-04-01",
    "date": "2021-09-02T13:57:11Z",
    "text": "Protecting Access to Biosimilars Act of 2019\n\nThis bill excludes biological products that were initially licensed under the Federal Food, Drug, and Cosmetic Act (FD&C Act) (e.g., insulin) from the exclusivity protections that delay the licensure of biosimilar products under the Public Health Service Act (PHS Act). (The Biologics Price Competition and Innovation Act of 2009 generally requires that biological products approved under the FD&C Act are treated as though they were approved under the PHS Act through March 23, 2020.)"
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Protecting Access to Biosimilars Act of 2019",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Public Health Service Act with respect to the treatment under section 351(k)(7) of such Act (relating to exclusivity for reference products) of certain products deemed to have a biologics license pursuant to section 7002 of the Biologics Price Competition and Innovation Act of 2009.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Protecting Access to Biosimilars Act of 2019",
      "type": "short"
    }
  ],
  "updated_at": "2022-11-01T18:47:25Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr2011.xml"
}